Knockdown of salusin-β contributes to the improvement of endothelial dysfunction, cardiac function, and cardiovascular remodeling in CHF by inhibiting vascular NAD(P)H oxidase-derived ROS generation, activating eNOS and increasing NO production. The gene discussed is FMO5; the disease is congestive heart failure.